The latest guidelines from the European Society of Cardiology recommend considering systematic electrocardiogram screening in individuals aged ≥75 years or those at high stroke risk as assessed by the CHA2DS2-VASc score.2 The present study suggests that NT-proBNP may better identify the appropriate subpopulation who would potentially benefit from AF screening and subsequent management. Here, NPPB is linked to atrial fibrillation.